共 50 条
Vascular photobiomodulation in the treatment of children with temporomandibular disorders: Study protocol for a randomized, controlled, blind, clinical trial
被引:1
|作者:
Ferreira Sertaje, Maria Roxana
[1
,2
]
Leal Goncalves, Marcela Leticia
[2
,3
]
Gomes, Andrea Oliver
[2
]
Bruno, Laura Hermida
[1
,2
]
Fossati, Ana Laura
[1
,2
]
Viarengo, Natalia Osorio
[1
,2
]
Santos, Elaine Marcilio
[3
]
Taboada Sobral, Ana Paula
[2
,3
]
Mesquita-Ferrari, Raquel Agnelli
[2
]
Santos Fernandes, Kristianne Porta
[2
]
Ratto Tempestini Horliana, Anna Carolina
[2
]
Motta, Lara Jansiski
[2
]
Bussadori, Sandra Kalil
[2
]
机构:
[1] Univ Catolica Uruguay UCU, Montevideo, Uruguay
[2] Univ Nove Julho, Post Grad Program Biophoton Appl Hlth Sci, Vergueiro St 235-249, BR-01504001 Sao Paulo, SP, Brazil
[3] Univ Metropolitana Santos, Postgrad Program Hlth & Environm, Santos, SP, Brazil
来源:
关键词:
ILIB;
jaw range of motion;
pain;
photobiomodulation;
temporomandibular disorder;
D O I:
10.1097/MD.0000000000031228
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: This study aims to verify if the use of intravascular laser irradiation of blood (ILIB) influences the reduction of pain and increases the range of motion in opening and closing of the mouth in children and adolescents with temporomandibular disorders (TMD). Methods: This will be a blind, randomized, and controlled clinical trial, which will be carried out on children between 6 and 12 years of age who enter the Catholic University of Uruguay, Faculty of Health Sciences, Postgraduate School, for treatment. To be included, children must present temporomandibular disorders, based on the diagnostic criteria will be the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). Forty-five participants will be randomized to three groups: Group 1-ILIB with 2 sessions of 20 minutes for 12 weeks (n = 15); Group 2-Placebo laser application with 2 sessions of 20 minutes for 12 weeks (n = 15); Group 3-Control with no treatment (n = 15). Irradiation will be performed by continuous and direct transcutaneous application to the radial artery, by means of a bracelet that inserts the laser beam. The laser to be used is infrared, power 100 mW +/- 20%, wavelength 808 nm +/- 10 nm, continuous application. RDC/TMD and pain evaluated through a visual analog scale will be the outcome measures. Discussion: Due to the low level of evidence, new studies are needed on the effect of ILIB in children with TMD.
引用
收藏
页数:4
相关论文